A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

~35 mi. (Brandywine, Maryland, +202 more cities)

Maryland Oncology Hematology

CLDN18 Expression, +1 more biomarker

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

modified FOLFOX6 regimen, +1 more drug

chemotherapy, +1 more type

Study of Sacituzumab Govitecan-hziy in Metastatic Urothelial Cancer

~35 mi. (Brandywine, Maryland, +32 more cities)

Maryland Oncology Hematology, P.A.

Urothelial Carcinoma

avelumab, +3 more drugs

chemotherapy, +2 more types

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

~41 mi. (Easton, Maryland, +576 more cities)

University of Maryland Shore Medical Center at Easton

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

~41 mi. (Easton, Maryland, +664 more cities)

University of Maryland Shore Medical Center at Easton

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

~41 mi. (Easton, Maryland, +240 more cities)

University of Maryland Shore Medical Center at Easton

Endometrial Adenocarcinoma, +5 more conditions

carboplatin, +2 more drugs

chemotherapy, +1 more type

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

~41 mi. (Easton, Maryland, +497 more cities)

University of Maryland Shore Medical Center at Easton

HER2 Positive

Breast Adenocarcinoma

atezolizumab, +4 more drugs

chemotherapy, +2 more types

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

~41 mi. (Easton, Maryland, +234 more cities)

University of Maryland Shore Medical Center at Easton

Prostate Adenocarcinoma

stereotactic body radiation therapy

radiation therapy, +1 more type

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

~41 mi. (Easton, Maryland, +822 more cities)

University of Maryland Shore Medical Center at Easton

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

carboplatin, +3 more drugs

chemotherapy

SWOG S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer

~41 mi. (Easton, Maryland, +210 more cities)

University of Maryland Shore Medical Center at Easton

Small Cell Lung Carcinoma

MRI surveillance

Other

Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study

~41 mi. (Easton, Maryland, +331 more cities)

University of Maryland Shore Medical Center at Easton

Deficient DNA Mismatch Repair (dMMR), +5 more biomarkers

Colorectal Adenocarcinoma

atezolizumab, +4 more drugs

chemotherapy, +2 more types

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

~42 mi. (Clinton, Maryland, +271 more cities)

Maryland Oncology Hematology

Prostate Adenocarcinoma

docetaxel, +2 more drugs

chemotherapy, +2 more types

Study of Sacituzumab Govitecan-hziy (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-programmed Death Protein 1 (PD-1)/Programmed Death Ligand 1 (PD-L1) Immunotherapy

~42 mi. (Clinton, Maryland, +17 more cities)

Maryland Oncology Hematology, P.A.

Non-Small Cell Lung Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type